V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011654 | 330004850 | 1.42 | 20.1 | Palliative (P) | 2015-05-21 | 2015-05-21 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330014284 | VINBLASTINE |
| 330011655 | 330004851 | 1.72 | 97 | Curative (C) | 2018-03-02 | 2018-03-02 | FLAG + Idarubicin | N | null | 330014292 | FLAG + IDARUBICIN |
| 330011656 | 330004852 | 1.68 | 47 | Curative (C) | 2016-08-17 | 2016-11-15 | Methotrexate intrathecal | 02 | null | 330014295 | METHOTREXATE INTRATHECAL |
| 330011657 | 330008654 | 1.79 | 86.4 | Palliative (P) | 2015-08-28 | 2015-08-28 | Docetaxel | N | null | 330014373 | DOCETAXEL |
| 330011658 | 330004864 | 1.8 | 53.1 | Curative (C) | 2016-02-18 | 2016-02-28 | VAC | N | Y | 330014435 | AZACITIDINE |
| 330011659 | 330004866 | 1.86 | 83.3 | Adjuvant (A) | 2013-12-15 | 2014-06-28 | Cisplatin + Etoposide po&iv 3 day | 2 | N | 330014444 | VINBLASTINE |
| 330011661 | 330004877 | 0 | 56.3 | Palliative (P) | 2013-02-27 | 2013-11-13 | Docetaxel | null | null | 330014546 | DOCETAXEL |
| 330011662 | 330004882 | 1.69 | 66.6 | Palliative (P) | 2013-08-15 | 2013-08-15 | Etoposide oral | 99 | N | 330014643 | ETOPOSIDE |
| 330011663 | 330004884 | null | 47 | Curative (C) | 2014-09-21 | 2014-09-22 | EURO-EWING | 02 | null | 330014652 | EURO-EWING |
| 330011664 | 330004886 | 1.69 | 111.9 | Not known (9) | 2018-05-30 | 2018-05-31 | NIVOLUMAB | N | N | 330014687 | DA |
| 330011666 | 330010701 | 0 | 15.2 | Palliative (P) | 2016-01-18 | 2016-01-30 | CNS Low Grade Glioma Vinblastine | 02 | N | 330014715 | AZACITIDINE |
| 330011667 | 330004893 | 0.87 | null | null | null | 2014-12-29 | Liposomal Doxorubicin (Caelyx) | null | null | 330014753 | LIPOSOMAL DOXORUBICIN |
| 330011669 | 330008678 | 1.81 | 61.6 | Palliative (P) | 2015-01-30 | 2015-06-20 | Cytarabine High Dose | null | null | 330014785 | CYTARABINE HIGH DOSE |
| 330011670 | 330004903 | 0 | 76.2 | Palliative (P) | 2015-10-02 | 2015-10-06 | Cytarabine High Dose | 02 | N | 330014843 | CYTARABINE HIGH DOSE |
| 330011672 | 330004907 | 1.84 | 68.2 | Curative (C) | 2016-07-20 | 2016-07-20 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330014861 | LIPOSOMAL DOXORUBICIN |
| 330011673 | 330008685 | 1.6 | 75.7 | Palliative (P) | 2015-01-26 | 2015-01-26 | Vinblastine | 2 | N | 330014877 | CISPLATIN + DOXORUBICIN |
| 330011674 | 330004913 | null | 75 | Curative (C) | null | 2013-12-20 | AML Interim Guidelines FLAG-Ida | N | Y | 330014897 | FLAG + IDARUBICIN |
| 330011675 | 330004920 | 1.78 | 95.4 | Curative (C) | 2015-05-12 | 2015-05-16 | NIVOLUMAB | N | N | 330014928 | VINBLASTINE |
| 330011677 | 330004938 | 1.7 | 87.7 | Palliative (P) | null | 2016-10-25 | CISPLATIN + ETOPOSIDE | N | N | 330015103 | VINBLASTINE |
| 330011678 | 330008698 | 1.78 | 54 | Curative (C) | 2015-05-25 | 2015-05-28 | Trabectedin | 02 | N | 330015114 | TRABECTEDIN |
| 330011679 | 330004940 | 0 | null | Palliative (P) | 2014-03-14 | 2014-04-20 | ETOPOSIDE | N | N | 330015115 | ETOPOSIDE |
| 330011680 | 330004943 | 1.63 | 56.3 | Neo-adjuvant (N) | 2014-10-02 | 2014-10-12 | EW EuroEwing 99 : VActI | N | N | 330015116 | EURO-EWING |
| 330011681 | 330004947 | null | 89.7 | null | 2018-06-28 | 2018-06-29 | Irinotecan + Temozolomide | 2 | Y | 330015123 | IRINOTECAN + TEMOZOLOMIDE |
| 330011682 | 330004951 | 1.68 | 75.5 | Palliative (P) | 2013-11-02 | 2013-11-10 | Docetaxel 75mg/m2 (21 day) | N | N | 330015137 | DOCETAXEL |
| 330011683 | 330004953 | null | null | Palliative (P) | 2014-09-15 | 2014-10-06 | VAC | 2 | null | 330015173 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330011684 | 330010719 | 1.5 | 62.2 | Palliative (P) | 2017-03-03 | 2017-03-03 | CAV | N | N | 330015176 | VINBLASTINE |
| 330011685 | 330004957 | 1.66 | 59.4 | Palliative (P) | 2016-02-17 | 2016-02-21 | ETOPOSIDE | 02 | N | 330015177 | ETOPOSIDE |
| 330011686 | 330004961 | 1.77 | 112 | Palliative (P) | 2014-05-17 | 2014-07-21 | CNS Low Grade Glioma Vinblastine | N | N | 330015195 | VINBLASTINE |
| 330011687 | 330004969 | null | 69.6 | Palliative (P) | 2016-10-31 | 2016-11-05 | Docetaxel | N | N | 330015244 | DOCETAXEL |
| 330011688 | 330004970 | 1.65 | 48.8 | Palliative (P) | 2018-07-08 | 2018-07-08 | Etoposide oral | null | null | 330015329 | ETOPOSIDE |
| 330011689 | 330004971 | 1.65 | 90.3 | null | 2015-11-01 | 2015-11-16 | Etoposide oral | N | null | 330015329 | ETOPOSIDE |
| 330011690 | 330004973 | 1.81 | 78.9 | Palliative (P) | 2017-08-30 | 2017-08-30 | GEMCARBO | 02 | N | 330015345 | GEMCARBO |
| 330011691 | 330008719 | 0 | 60 | Disease modification (D) | null | 2013-11-03 | Liposomal Doxorubicin 50mg/m2 | null | Y | 330015523 | LIPOSOMAL DOXORUBICIN |
| 330011692 | 330004988 | null | 106.9 | Palliative (P) | 2017-09-18 | 2017-09-26 | Trabectedin | N | null | 330015593 | TRABECTEDIN |
| 330011693 | 330004992 | 0 | 0 | Curative (C) | 2017-10-09 | 2017-10-13 | Irinotecan + Temozolomide | 02 | N | 330015651 | IRINOTECAN + TEMOZOLOMIDE |
| 330011694 | 330004998 | 1.79 | 73 | null | 2015-08-19 | 2017-04-17 | Azacitidine | 02 | null | 330015679 | CISPLATIN + DOXORUBICIN |
| 330011695 | 330012481 | null | 35.5 | Curative (C) | 2015-07-12 | 2016-02-15 | EW EuroEwing 99 : VActC | 02 | N | 330015829 | EURO-EWING |
| 330011696 | 330005005 | 1.67 | 83.4 | Curative (C) | 2015-03-23 | 2015-03-23 | Methotrexate intrathecal | null | null | 330015848 | METHOTREXATE INTRATHECAL |
| 330011697 | 330010737 | 1.95 | 69 | Palliative (P) | 2019-10-25 | 2019-10-25 | Docetaxel 75mg/m2 (21 day) | N | N | 330015869 | DOCETAXEL |
| 330011698 | 330005010 | 1.9 | 77.1 | Disease modification (D) | 2013-08-01 | 2013-08-01 | DA 3+8 | 2 | N | 330015927 | VINBLASTINE |
| 330011699 | 330010739 | 1.76 | 61.4 | Neo-adjuvant (N) | 2013-12-04 | 2013-12-05 | Vinblastine | Y | N | 330015927 | CAV |
| 330011700 | 330005013 | 1.7 | 65.75 | Palliative (P) | 2017-07-30 | 2017-07-30 | CYTARABINE + DAUNORUBICIN | N | N | 330015964 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330011701 | 330005015 | 1.62 | 65.8 | Disease modification (D) | 2014-10-04 | 2014-10-08 | DA 3+8 | N | N | 330015969 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330011702 | 330005017 | 1.65 | 55 | Palliative (P) | 2013-09-30 | 2013-09-30 | Liposomal Doxorubicin (Myocet) | N | N | 330015971 | LIPOSOMAL DOXORUBICIN |
| 330011703 | 330005021 | 1.49 | 56.3 | Palliative (P) | 2016-07-21 | 2016-08-10 | Temozolomide 150mg/m2 | N | N | 330015996 | DA |
| 330011704 | 330005027 | 1.7 | 89.7 | Palliative (P) | 2014-08-02 | 2014-08-02 | CNS Low Grade Glioma Vinblastine | 02 | N | 330016047 | CAV |
| 330011705 | 330005029 | 1.83 | 78 | Adjuvant (A) | null | 2014-01-23 | DA 3 + 10 | null | null | 330016049 | VINBLASTINE |
| 330011706 | 330005035 | 1.71 | 64 | Neo-adjuvant (N) | null | 2015-12-05 | Cisplatin + Doxorubicin | N | N | 330016135 | CAV |
| 330011707 | 330005038 | 1.63 | 7.7 | Palliative (P) | 2019-02-11 | 2019-02-12 | CISPLATIN + ETOPOSIDE | 02 | N | 330016168 | CISPLATIN + ETOPOSIDE |
| 330011708 | 330005043 | 0 | 47.3 | Curative (C) | 2017-07-17 | 2017-07-20 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 330016204 | CISPLATIN + DOXORUBICIN |